Could AI be the key to unlocking breakthrough treatments for Alzheimer’s? In this CNBC Money Movers segment, SandboxAQ CEO Jack Hidary and investor Jim Breyer discuss how advanced AI is transforming healthcare, dramatically reducing drug discovery timelines for diseases like Alzheimer’s, cancer, Parkinson’s, and more.
In honor of World Alzheimer’s Month, Jack explains how SandboxAQ is leveraging Large Quantitative Models (LQMs) and partnering with NVIDIA and UCSF to identify critical compounds for neurodegenerative diseases in under 18 months—compared to the typical 10-year development cycle. Discover how AI-driven models are optimizing drug development, increasing success rates, and accelerating the path to clinical trials.
Jim Breyer adds his insights on why SandboxAQ is at the forefront of AI and quantum innovation, creating real-world impact across industries, from life sciences to financial services.
0:00 – Introduction
0:30 – AI, Quantum, and Healthcare
1:20 – Reducing Drug Discovery Timelines with LQMs
2:15 – Partnerships with NVIDIA, UCSF, and Others
3:00 – The Future of AI and Quantum in Healthcare
Don’t miss this deep dive into how AI is reshaping the future of healthcare and offering new hope for patients.
Subscribe to stay updated on the latest in cybersecurity and quantum technologies!
Want to learn more? Visit
#WorldAlzheimersMonth #AI #Quantum #DrugDiscovery #HealthcareInnovation #SandboxAQ #CNBC #AlzheimersResearch #AIinHealthcare #NVIDIA #Biopharma #LQMs
source
